The Florida-based healthcare company, already a leading name in cardiac data management, said the acquisition will help its technology reach more heart teams than ever before.

The Department of Energy is concerned about AI’s mammoth appetite for, well, energy.

AI and patient care are “top of mind” for healthcare executives in 2024. The pairing seems opportune, since the surveyed leaders see the burgeoning technology as a key tool for improving the perennial mission.

Ideally, educational pamphlets for patients should be written at a sixth grade reading level, according to the American Medical Association.

Beginning September 10, breast imaging facilities will be required to notify patients about the density of their breasts, among other regulatory changes. 

The FDA ruled that this is a Class I recall due to the significant risks for patients. Customers are not required to return the devices, however. Inari Medical has provided updated warnings and recommendations that should be followed. 

Researchers combined data from three well-known clinical trials—NOTION, Evolut Low Risk and PARTNER 3—and evaluated thousands of low-risk patients who presented with severe aortic stenosis. 

Regulators emphasized that these devices should not be used due to significant safety risks.